Manitoba Liquor & Lotteries is providing $1.35 million towards research aimed at improving early diagnosis, intervention and prevention of Fetal Alcohol Spectrum Disorder (FASD). The funding is awarded to the Canada-Israel International Fetal Alcohol Consortium (CIIFAC), made up of research teams from the University of Manitoba and the Hebrew University of Jerusalem.
The CIIFAC’s research is focused on:
“This funding from Manitoba Liquor & Lotteries supports the Province of Manitoba’s cross-departmental FASD Strategy,” said the Honourable Kevin Chief, Minister of Children and Youth Opportunities. “The goals of the strategy are to support women to have healthy pregnancies and to provide individuals living with FASD and their families with the services and supports they need to live successfully.”
“Manitoba Liquor & Lotteries is very pleased to support this important research,” said Winston Hodgins, President and CEO of Manitoba Liquor & Lotteries. “Our corporation is committed to social responsibility and has implemented FASD-related public awareness programs for many years. Consuming alcohol during pregnancy is directly related to the development of FASD – therefore, we are committed to FASD research and prevention.”
Manitoba Liquor & Lotteries commits two per cent of annual net income for liquor and gaming social responsibility programs in research, education, and awareness. This year, that amounts to $11.6 million.
“This new funding strengthens our research partnership on FASD with the Hebrew University,” said Dr. Digvir Jayas, Vice-President (Research and International) and Distinguished Professor at the University of Manitoba. “Our research teams are seeking innovative approaches to understanding FASD in an effort to enhance the well-being of individuals, families and communities affected by FASD in Manitoba and beyond.”
The $1.35 million supports three research projects, led in Manitoba by Drs. Brenda Elias, assistant professor in the U of M’s department of community health sciences, Geoff Hicks, director of the U of M’s regenerative medicine program (previous story here), and Miyoung Suh, associate professor of human nutritional sciences at the U of M. Together, the projects aim to:
The research consortium was made possible through the work of the Canadian Friends of the Hebrew University of Jerusalem (CFHU), which was instrumental in bringing together all of the stakeholders.
“We are delighted at the continued success of the partnership for FASD research between the University of Manitoba and the Hebrew University,” said Rami Kleinmann, President and CEO, CFHU. “The funding from Manitoba Liquor & Lotteries speaks to the importance of collaborative research in addressing the complex medical and social implications of conditions such as FASD.”